<DOC>
	<DOC>NCT01161472</DOC>
	<brief_summary>The study is designed to evaluate elements of cognitive function in subjects receiving either fesoterodine or alprazolam.</brief_summary>
	<brief_title>A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects</brief_title>
	<detailed_description>Evaluation of cognitive function</detailed_description>
	<mesh_term>Alprazolam</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Adult healthy volunteers 65 years and over with minimum MMSE of 26 Prohibited concomitant medications Confounding medical conditions Clinically significant comorbid diseases Hypersensitivity or contraindications to fesoterodine or active control</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>